subject: India Promises To Be Amongst The Most Lucrative Diabetes Markets In The World [print this page] Indian Diabetes Market Report & Outlook For 2010-2015
Numerous factors such as the worlds largest diabetes patient pool, the success of newly launched innovative drugs, increasing diagnosis and drug treated rates,
and a rapidly growing market are driving all major pharmaceutical manufacturers in this Market. ( http://www.bharatbook.com/detail.asp?id=152255&rt=Indian-Diabetes-Market-Report-Outlook-For-2010-2015.html )
A growing drug treated population coupled with the launch of several new agents is expected to drive the Indian diabetes market to US$1.4 Billion by 2015
In 2009, the Market for Non-insulin Anti-diabetics was worth US$ 306 Million. Growth in this market in the next five years will be driven by the strong uptake of novel drugs such as DPP-IV inhibitors and GLP-1 analogues
Although the market for Non-insulin anti-diabetics is highly genericized, the success of Mercks Januvia (Sitagliptin) Suggests that there exists a large segment in the Indian population that can afford highly priced but innovative drugs
The Insulin market in India is presently dominated by intermediate rapid acting Insulins. The popularity of long acting Insulin is, however, rapidly increasing.
Unlike the Non-Insulin anti-diabetics Market, the market for Insulin is highly concentrated with the top three players accounting for 88% of the total market.
It Expects the Insulin market to grow at a CAGR of 25% between 2010-2015 reaching sales over US$ 448 Million by 2015
Forecasts: The report provides forecasts on: Total Number of Diabetes patients, Diagnosis and treatment rates in India, Total Diabetes Market, Total Non-insulin diabetes Market, Glitazones, Biguanides, Sulphonylureas, Alpha-Glycosidase Inhibitors, DPP-IV inhibhitors, GLP-Agonists, Glinides, All other Non-insulin Antidiabetes classes, Total Insulin Market
Key Questions Answered in this report
What is the total size of the diabetes population in India and what are its characteristics?
What area the diagnosis and drug treatment rates for diabetes in India?
What are the key factors driving the growth of diabetes medications in India?
What is the Size and Breakup of the total Diabetes Market in India?
What is the Size and Breakup of the total Non-Insulin diabetes market in India?
What is the Size and Breakup of the total Insulin diabetes market in India?
Who are the key players in the Indian diabetes market and how has their performance been in the last five years?
What is the outlook of the Indian diabetes market in the next five years?
Which novel products are expected to be launched in the next five years?
Which therapy classes will show the highest growth in the next five years?
What area the road blocks in the Indian diabetes market?
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=152255&rt=Indian-Diabetes-Market-Report-Outlook-For-2010-2015.html
